Article

Oncogenic memory underlying minimal residual disease in breast cancer

2020-01-24

Abstract excerpt

<h4>ABSTRACT</h4> Tumor relapse is responsible for most breast cancer related deaths 1,2 . The disease recurrence stems from treatment refractory cancer cells that persist as minimal residual disease (MRD) for years following initial therapy 3 . Yet, the molecular characteristics defining the malignancy of MRD remain elusive due to difficulties in observing these rare cells in patients or in model organisms. He...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: db0a1d16-7ff1-53b2-9ed0-d9109cdfdbf4
DOI: 10.1101/2020.01.23.916510

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Oncogenic memory underlying minimal residual disease in breast cancerDOI 10.1101/2020.01.23.916510Read

Drug-tolerant persister cell in cancer: reversibility, microenvironmental interplay, and therapeutic strategiesSemantic proximity Read

Adaptation and Selection Shape Clonal Evolution During Residual Disease and RecurrenceSemantic proximity Read

Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylationSemantic proximity Read

Gene expression predicts dormant metastatic breast cancer cell phenotype.Semantic proximity Read

Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies.Semantic proximity Read

Metabolic orchestration of drug-tolerant persister cells in cancerSemantic proximity Read

Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancerSemantic proximity Read

Cellular dormancy in minimal residual disease following targeted therapySemantic proximity Read

Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast CancerSemantic proximity Read

Enforced ZFP281 expression delays breast cancer initiation and can provide lifelong protection against breast cancer metastasisSemantic proximity Read

Breast cancer dormancy is associated with a 4NG1 state and not senescenceSemantic proximity Read

Decoding the adaptive survival mechanisms of breast cancer dormancySemantic proximity Read